Clinical Trial Update: DIAMOND AF Post-Approval Study

View source ↗

Summary

The DIAMOND AF post-approval study for paroxysmal atrial fibrillation sponsored by Medtronic Cardiac Ablation Solutions has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Atrial Fibrillation

Snippet

Sponsor: Medtronic Cardiac Ablation Solutions | Conditions: Paroxysmal Atrial Fibrillation | Status: TERMINATED